Ehrlich, P.: Beitrage zur Kenntnis der Anilinfarbungen und ihrer Verwendung in der mikroskopischen Technik, Arch Mikr Anat13:263-277, 1877.
2.
Riley, J.F.: The Mast Cells, Edinburgh: Livingstone , 1959.
3.
Schauer, A.: Die Mastzelle, Stuttgart: G. Fischer , 1964.
4.
Selye, H.: The Mast Cells, Washington, DC: Butterworths, 1965.
5.
Keller, R.: Tissue Mast Cells in Immune Reactions, Basel: S. Karger, New York: American Elsevier, 1966 .
6.
Sagher, F., and Even-Paz, Z.: Mastocytosis and the Mast Cell, Basel: S. Karger, 1967.
7.
Fernex, M.: The Mast-Cell System. Its Relationship to Atherosclerosis, Fibrosis and Eosinophils , Basel: S. Karger, 1968.
8.
Johnson, A.R. , and Moran, N.C.: Selective Release of Histamine from Rat Mast Cells by Compound 48/80 and Antigen, Amer J Physiol216:453-459, 1969.
9.
KELLER, R.: Unpublished results.
10.
Humphrey, J.H.: in Austen, K.F., and Becker, E.L. (eds): Biochemistry of the Acute Allergic Reactions , Oxford: Black-well, 1968, p 249.
11.
Koopman, W.J. ; Orange, R.P.; and Austen , K.F.: Immunochemical and Biological Properties of Rat IgE: III. Modulation of the IgE-Mediated Release of Slow-Reacting Substance of Anaphylaxis by Agents Influencing the Level of Cyclic 3',5'-adenosine monophosphate, J Immunol105:1096-1102, 1970.
12.
Wilhelmi, G. : Influence of Noc-Steroidal Anti-Inflammatory Drugs on Experimental Serositis, Excerpta Med Int Congr Ser82:174-179, 1965.
13.
Wilhelmi, G. : Esperienze comparative sulle proprieta farmacologiche dei vari sali del fenilbutazone e sulla somministrazione contemporanea di acido 1-ascorbico, Il Farmaco, Ed Scientif13:922-933, 1958.
14.
Wilhelmi, G. : Newer Pharmacological Data on Oxyphenbutazone , Jap J Pharmacol15:187-198, 1965.
15.
Eder, M., and Schauer, A.: Fermenthistochemische und experimentelle Untersuchungen an Gewebemastzellen , Beitr Path Anat124:251-277, 1961.
16.
Smith, D.D. , and Miles, A.A.: The Role of Histamine in Early Bacterial Inflammation of the Rat Peritoneal Cavity, Brit J Exp Path41:305-312, 1960.
Enerbäck, L. : Mast Cells in Rat Gastrointestinal Mucosa. 2. Dye-binding and Metachromatic Properties, Acta Path Microbiol Scand66:303-312, 1966.
19.
Keller, R.; Mueller-Eckhardt, E.; Kayser, F.-H.; and Keller, H.U.: Interrelations Between Different Types of Cells: I. A Comparative Study of the Biological Properties of a Cationic Polypeptide From Lysosomes of Polymorphonuclear Leukocytes and Other Cationic Compounds, Int Arch Allerg33:239-258, 1968.
20.
Keller, R., and Ogilvie, B.M.: The Effects of Drugs on Worm Expulsion in the Nippostrongylus brasiliensis Infected Rat: A Discussion of the Interpretation of Drug Action, Parasitology, in press.
21.
Majno, G.: Mechanisms of Abnormal Vascular Permeability in Acute Inflammation, in Thomas, C.; Uhr, J.W.; and Grant, L. (eds): Injury, Inflammation and Immunity, Baltimore: Williams and Wilkins, 1964, pp 58-93.
22.
Majno, G., and Palade, G.E.: Studies on Inflammation: I. The Effect of Histamine and Serotonin on Vascular Permeability: An Electron Microscopic Study, J Biophys Biochem Cytol11:571, 1961.
23.
Riley, J.F. , and West, G.B.: Tissue Mast Cells. Studies With a Histamine-Liberator of Low Toxicity (Compound 48/80), J Path Bact69:269-282, 1955.
24.
Roth, E.; Noltenius, H.; and Dehlert, W.: Autoradiographische Untersuchungen zur DNS-Neubildung und zum Sulfateinbau in Gewebemastzellen, Frankfurt Z Path73:40-51, 1963.
25.
Schayer, R.W. ; Rothschild, Z.; and Bizony, P.: Increase in Histidine Decarboxylaseactivity of Rat Skin Following Treatment With Compound 48/80, Amer J Physiol196:295-298, 1959.
26.
Falke, D., and Netter, K.J.: Die Hemmung der Riesenzellbildung durch das sogenannte Compound 48/80 nach der Infektion mit dem Herpesvirus hominis. I. Wirkung auf die Virussynthese, Arch ges Virusforsch28:308-324, 1969.
27.
Mishra, B.P., and Sanyal, R.K.: Staphylococcal Infection in Histamine and 5-Hydroxytryptamine Depleted Rat , J Pharm Pharmacol11:127-128, 1959.
28.
Wilhelm, D.L.: The Pattern and Mechanism of Increased Vascular Permeability in Inflammation , in Inflammation Biochemistry and Drug Interaction, Amsterdam : Excerpta Med Found, 1969, pp 136-144.
29.
Spector, W.G. , and Willoughby, D.A.: Experimental Suppression of the Early Inflammatory Phenomena in Turpentine Pleurisy in Rats, Nature181:708-709, 1958.
30.
Bhatt, K.G.S. , and Sanyal, R.K.: The Role of Histamine and 5-Hydroxytryptamine in Inflammatory Processes, J Pharm Pharmacol16:385-393, 1964.
31.
Sanyal, R.K. , and West, G.B.: The Role of Histamine and 5-Hydroxytryptamine in Injury, Int Arch Allergy26:362-372, 1965.
32.
Sheldon, W.H. , and Bauer, H.: Tissue Mast Cells and Acute Inflammation in Experimental Cutaneous Mucormycosis of Normal, 48/80-treated, and Diabetic Rats, J Exp Med112:1069-1083, 1960 .